# Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease

> **NCT05385315** · — · RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 70 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05385315
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-13
- **Primary completion:** 2025-10-16
- **Final completion:** 2025-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385315, "Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT05385315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*